Pulmonx (LUNG) Financials

Pulmonx Corp (LUNG) is a medical technology company that specializes in the development and commercialization of minimally invasive medical devices for the treatment of respiratory diseases. The company's financial performance is reflected in its income statement, which provides a detailed breakdown of its revenues, expenses, and profitability. The income statement shows the company's gross profit, which is the difference between its total revenue and the cost of goods sold. It also includes the company's operating expenses, such as research and development costs, sales and marketing expenses, and general and administrative expenses. After deducting all expenses, the income statement shows the company's EBIT (earnings before interest and taxes). EBITDA (earnings before interest, taxes, depreciation, and amortization) is another measure of the company's profitability, which accounts for non-cash expenses. Both EBIT and EBITDA provide insights into the company's operational performance and profitability.

Pulmonx Corp's net income from stockholders represents the amount of profit that is attributable to the company's shareholders after all expenses and taxes have been deducted. This figure is important as it reflects the company's bottom line performance. Pulmonx Corp's total revenue is the sum of its product sales, licensing fees, and any other sources of income. It gives a comprehensive view of the company's overall financial performance. Moving on to the balance sheet, it provides information on the company's financial position at a specific point in time. It includes assets, liabilities, and stockholders' equity. Cash equivalents are highly liquid assets that can be easily converted into cash. They are included in the company's balance sheet under the current assets category. Net debt is calculated by subtracting cash and cash equivalents from total debt. Stockholders' equity represents the residual interest in the assets of the company after deducting liabilities, and it reflects the shareholders' ownership in the company.

Pulmonx Corp's total assets represent all the resources that the company owns. These include cash, investments, property, plant, and equipment, and other tangible and intangible assets. Total debt represents the company's obligations to repay loans and other borrowings. It provides insight into the company's leverage and financial risk. Total liabilities encompass all the financial obligations and debts that the company owes to its creditors and other parties. Cash flow refers to the movement of money in and out of the company. It includes cash from operating activities, investing activities, and financing activities. Operating cash flow represents the cash generated from the company's core operations, while investing cash flow includes cash flows related to investments in assets or acquisitions. Financing cash flow includes cash flows related to the company's financing activities, such as raising capital through debt or equity issuance. Free cash flow is the amount of cash that the company has left after deducting capital expenditures and other investments.